Commentaries on “The Immunoregulatory Disturbance in Autoimmune Thyroid Disease”

References

• Adams DD. Thyroid-stimulating autoantibodies. Vitamins and Hormones 1980; 38: 119–203
   PubMedGoogle Scholar
• Mackenzie W A, Davies TF. An intrathyroidal T-cell clone specifically cytotoxic for human thyroid cells. Immunol. 1987; 61: 101–103
   PubMed Web of Science ®Google Scholar
• Iida Y, Konishi J, Kasagi K, Arai K, Tokuda Y, Tozikuka K. Inhibition of thyrotropin-induced growth of rat thyroid cells, FRTL-5, by immunoglobulin G from patients with primary myxoedema. J Clin Endocrinol Metab 1987; 64: 124–130
   PubMedGoogle Scholar
• Knight A, Adams DD. Autoantibodies with intrinsic biological activity. Hormone Research 1980; 13: 69–80
   Google Scholar
• Kriss J P, Pleshakov V, Rosenblum A L, Holderness M, Sharp G, Utiger R. Studies on the pathogenesis of the ophthalmopathy of Graves' disease. J Clin Endocrinol Metab 1967; 27: 582–593
   PubMedGoogle Scholar
• Zakarija M, McKenzie JM. Immunochemical characterisation of TSab: evidence against its polyclonal nature. Thyroid Research VIII. Australian Academic of Science, Canberra 1980; 669–772
   Google Scholar
• Zakarija M. Immunochemical characterisation of the thyroid-stimulating antibody of Graves' diseae. J Clin Lab Immunol 1983; 10: 77–85
   PubMedGoogle Scholar
• Knight J G, Laing P, Knight A, Adams D D, Ling NR. Thyroid stimulating autoantibodies usually contain only lambda light chains: evidence for the forbidden clone theory. J Clin Endocrinol Metab 1986; 62: 342–347
   PubMed Web of Science ®Google Scholar
• Schatz D A, Barrett D J, Maclaren N K, Riley WJ. Polyclonal nature of islet cell antibodies in insulin dependent diabetes. Autoimmunity 1988; 1: 45–49
   Google Scholar
• Tada T. Help, suppression and specific factors. Fundamental Immunology, W. E. Paul. Raven, New York 1984; 481–517
   Google Scholar
• Jensenius J C, Williams AF. The T lymphocyte antigen receptor - paradigm lost. Nature 1982; 300: 583–588
   Google Scholar
• Saito H, Kranz D M, Takagaki Y, Mayday A C, Eisen H N, Tonegawa S. Complete primary structure of a heterodimeric T-cell receptor deduced from cDNA sequences. Nature 1984; 309: 757–762
   PubMed Web of Science ®Google Scholar
• Howard J. The T-cell antigen receptor - paradigm regained. Immunol Today 1984; 5: 188–189
   PubMedGoogle Scholar
• Smith KA. Lymphocyte regulation of T cell and B cell functions. Fundamental Immunology, W. E. Paul. Raven Press, New York 1984; 559–576
   Google Scholar
• Malkovsky M, Medawar PB. Is immunological tolerance (non-responsiveness) a consequence of interleukin 2 deficit during the recognition of antigen. Immunol Today 1984; 5: 340–343
   Google Scholar
• Taussig MJ. Demonstration of suppressor T cells in a population of “educated” T cells. Nature 1974; 248: 236–238
   Google Scholar
• Nachtigal D, Zan-Bar I, Feldman M. The role of specific suppressor T cells in immune tolerance. Transplant Rev 1975; 26: 87–105
   Google Scholar
• Amino N, Degroot LJ. Insoluble particulate antgien(s) in cell-mediated immunity of antoimmune thyroid disease. Metabolism 1975; 24: 45–56
   Google Scholar
• Matsui Y, Beall G. N, Chopra I J, Solomon D H, Kruger S, Beall M. Assays for antigen-stimulated lymphocyte-derived migration enhancement and inhibition factors from patients with thyroid diseases and their relatives. Acta Endocrinol 1977; 86: 733–741
   Google Scholar
• Moller G. Editorial: Do Suppressor T cells exist. Scand J. Immunol. 1988; 27: 247–250
   PubMed Web of Science ®Google Scholar
• Andrada J A, Rose NR, Kite J H, Jr. Experimental thyroiditis in the rhesus monkey. IV. The role of thyroglobulin and cellular antigens. Clin Exp Immunol 1968; 3: 133–151
   Google Scholar
• Rose N R, Bacon L D, Sundick R S, Kong Y M, Esquivel P, Bigazzi PE. 1977 Genetic regulation in autoimmune thyroiditis. Autoimmunity - Genetic, Immunologic, Virologic and Clinical Aspects, Chapter 3, N Talal. Academic Press, Inc., New York 1977; 63–87
   Google Scholar
• Rose N R, Bacon L D, Sundick R S, Kong YM. 1978 The role of genetic factors in autoimmunity. The Menarini Series on Immunopathology - First Symposium on Organ specific Autoimmunity, PA Meischer, L Bolis, S Gorini, TA Lambo, GJV Nossal, G Torrigiani. Schwabe and Co., Ltd., BaselSwitzerland 1987; 225–238
   Google Scholar
• Vladutiu A O, Rose NR. Autoimmune murine thyroiditis. Relation to histocompatibility (H-2) type. Science 1971; 174: 1137–1139
   PubMed Web of Science ®Google Scholar
• Beisel K W, David C S, Giraldo A A, Kong Y M, Rose NR. Regulation of experimental autoimmune thyroiditis: Mapping of susceptibility to the I-A subregion of the mouse. H-2. Immunogenetics 1982; 15: 427–430
   PubMed Web of Science ®Google Scholar
• Ada G L, Rose NR. The initiation and early development of autoimmune disease. Clin Immunol Immunopathol 1988; 47: 3–9
   PubMedGoogle Scholar
• Burek C L, Rose N R, Najar G M, Hoffman W H, Gimelfarb A, Zmijweski C M, Polesky H F, Hoffman WM. Autoimmune thyroid disease. Immunogenetics, Chapter 9, GS Panayi, CS David. Butterworths, London 1984; 207–233
   Google Scholar
• Bacon L D, Polley C R, Cole R K, Rose NR. Genetic influences on spontaneous autoimmune thyroiditis in (CSxOS) F2 chickens. Immunogenetics 1981; 12: 339–349
   PubMedGoogle Scholar
• Kuppers R C, Neu N, Rose NR. Animal models of autoimmune thyroid disease. Immunogenetics of Endocrine Disorders, Chapter 6, NR Farid. Alan R. Liss, Inc., New York 1988; 111–131
   Google Scholar
• Lillehoj H S, Rose NR. Relationship between genetic control of T-cell mitogen response and thyroiditis susceptibility in inbred rats. Cell Immunol 1981; 62: 156–163
   Google Scholar
• Rose N R, Bacon L D, Sundick RS. Genetic determinants of thyroiditis in the OS chicken. Transplant Rev 1976; 31: 264–285
   PubMedGoogle Scholar
• Kojima A, Prehn RT. Genetic Susceptibility to post-thymectomy autoimmune diseases in mice. Immunogenetics 1981; 14: 15–27
   PubMed Web of Science ®Google Scholar
• Sundick R S, Herdegen D M, Brown T R, Bagchi N. The Incorporation of dietary iodine into thyroglobulin increases its immunogenicity. Endocrinology 1987; 120: 2078–2084
   PubMed Web of Science ®Google Scholar
• Champion B R, Rayner D C, Byfield P G, Page K R, Chan C TJ, Roitt IM. 1987 Critical Role of iodination for T cell recognition of thyroglobulin in experimental murine thyroid autoimmunity. J Immunol 1987; 139: 3665–3670
   PubMed Web of Science ®Google Scholar
• Weetman A P, Volkman D J, Burman K D, Fauci AS. Activation, proliferation and differentiation of circulating B cells in autoimmune thyroid disease. J Immunol 1985; 135: 3138–43
   PubMed Web of Science ®Google Scholar
• Strom H, Al-Balaghi S, Möller E. No demonstrable association between HLA-DR4 and in vitro collagen reactivity as determined by the production of leukocyte inhibition factor. Tissue Antigens 1984; 24: 174–83
   PubMed Web of Science ®Google Scholar
• Ludgate M E, Ratanachaiyavong S, Weetman A P, Hall R, McGregor AM. Failure to demonstrate cell-mediated immune response to thyroid antigens in Graves' disease using in vitro assays of lymphokine-mediated migration inhibition. J Clin Endocrinol Metab 1985; 60: 98–102
   PubMed Web of Science ®Google Scholar
• Damle N K, Mohagheghpour N, Engleman EG. Soluble antigen-primed inducer T cells activate antigen-specific T cells in the absence of antigen-pulsed accessory cells: phenotypic definition of suppressor-inducer and suppressor effector cells. J Immunol 1984; 132: 644–50
   Google Scholar
• Rich R R, ElMasray M N, Fox EJ. Human suppressor T cells: induction, differentiation and regulatory functions. Human Immunol 1986; 17: 369–87
   Google Scholar
• Palacios R, Möller G. T cell growth factor abrogates concanavalin A-induced suppressor cell function. J Exp Med 1981; 153: 1360–65
   PubMedGoogle Scholar
• Gunther J, Haas W, Von Boehmer H. Suppression of T cell responses through competiition for T cell growth factor. Eur J Immunol 1982; 12: 247–49
   Google Scholar
• Weetman A P, McGregor A M, Hall R. Evidence for an effect of antithyroid drugs on the natural history of Graves' disease. Clin Endocrinol 1984; 21: 163–72
   PubMed Web of Science ®Google Scholar
• Allen E M, Rajatanavin R, Nogimori T, Cushing G, Ingbar S H, Braverman LE. The effect of methimazole on the development of spontaneous lymphocytic thyroiditis in the diabetes-prone BB/W rat. Amer J Med Sci 1986; 29: 267–71
   Google Scholar
• Cohen S B, Weetman AP. Antithyroid drugs ameliorate thymectomy-induced experimental autoimmune thyroiditis. Autoimmunity 1988; 1: 51–8
   Google Scholar
• Hassman R, Weetman A P, Gunn C. The effect of hyperthyroidism on experimental autoimmune thyroiditis in the rat. Endocrinology 1985; 116: 1253–58
   PubMed Web of Science ®Google Scholar
• Pacini F, De Groot LJ. Studies of immunoglobulin synthesis in cultures of peripheral T and B lymphocytes: reduced T-suppressor cell activity in Graves' disease. Clin Endocrinol 1983; 18: 219–32
   Google Scholar
• Lobo-Yeo A, Mieli-Vergani G, Kenna G, Mowat A P, Vergani D. Evidence of impaired antigen non-specific but normal antigen-specific suppressor cell function in children with autoimmune chronic active hepatitis. Clin Exp Immunol. 1987; 70: 411–16
   Google Scholar
• Weetman AP. The effect of the anti-thyroid drug methimazole on interleukin-1 and interleukin-2 levels in vitro. Clin Endocrinol 1986; 25: 133–42
   PubMed Web of Science ®Google Scholar
• Tötterman TH, Karlsson F A, Bengtsson M, Mendel-Hartvig I. Induction of circulating activated suppressor like T cells by methimazole therapy for Graves' disease. New Engl J Med 1987; 316: 15–22
   PubMed Web of Science ®Google Scholar
• Modlin R L, Kato H, Mehra V. Genetically restricted suppressor T cell clones derived from lepromatous leprosy lesions. Nature 1986; 322: 459–61
   PubMed Web of Science ®Google Scholar
• Solomon D H, Chopra I J, Chopra U, Smith FJ. Identification of subgroups of euthyroid ophthalmic Graves ophthalmopathy. N Engl J Med 1977; 296: 181–185
   PubMed Web of Science ®Google Scholar
• Volpé R. Autoimmune thyroid disease. Autoimmunity and endocrine disease, R. Volpé. Marcel Dekker, New York 1985; 109–285
   Google Scholar
• Wolf M, Misaki T, Bech K, Larsen J H, Ingbar SH. Immunoglobulins of patients recovering form Yersinia enterocolitica infections exhibit Graves' disease-like activity in human thyroid membranes. Clin Res 1988; 36: 556A
   Google Scholar
• Sakata S, Matsuda M, Komaki T, Kojima N, Yabuuchi E, Miura K. Production of anti-TSH receptor antibodies in the Eighth International with Yersinia enterocolitica. Proceedings of the Eighth International Congress of Endocrinology, KyotoJapan, July 17–23, 1988, Abstract No. 12–18–073
   Google Scholar
• Calder E A, Irvine WJ. Cell mediated immunity and immune complexes in thyroid disease. Clin Endo Met 1975; 4: 318
   Google Scholar
• Corazza G R, Sachielli P, Londei M, Frisoni M., Gasparini G. Gluten specific suppressor T cell function in coeliac disease. Gut 1986; 27: 392–398
   PubMed Web of Science ®Google Scholar
• Iitaka M, Aguayo J, Row V V, Volpé R. Studies of the suppressor T cell function in the induction of antithyroid microsomal antibody secreting cells. J Clin Endo Metab 1988; 66: 708–714
   PubMed Web of Science ®Google Scholar
• Mori H, Hamada N, De Groot LJ. Studies on thyroglobulin specific suppressor T cell function in autoimmune thyroid disease. J Clin Endo Metab 1985; 60: 306–312
   Google Scholar
• Davies T F, Platzer M. The T cell suppressor defect in autoimmune thyroiditis: Evidence for a high set “immunostat.” Clinical and Experimental. Immun 1986; 63: 73–78
   Google Scholar
• Schumm-Draeger P M, Usadel K H, Bohm B O, Maul F D, Wenisch H JC, Senekowitsch R, Pickardt CR, Schoffling K. Thyrotoxic effect of high iodine doses on zenotransplanted autoimmune thyroid tissue in athymic nude mice. Acta Endo 1987; 115: 118–121, Supplement 281
   Google Scholar
• Iitaka M, Aguayo J F, Iwatani Y, Row V V, Volpe R. In vitro induction of anti-thyroid microsomal antibody secreting cells in peripheral blood mononuclear cells from normal subjects. J Clin Endo Metab, In press
   Google Scholar
• Aguayo J, Iitaka M, Row V V, Volpe R. Studies of HLA-DR expression on cultured human thyrocytes: Effect of antithyroid drugs and other agents on interferon-gamma-induced HLA-DR expression. J Clin Endo Metab 1988; 66: 903–908
   PubMed Web of Science ®Google Scholar
• Aguayo J, Michaud P, Iitaka M, De Grott L J, Row V V, Volpé R. Expression of thyroid peroxidase and thyroglobulin antigen release by cultured human thyrocytes. Effect of Methimazole. Autoimmunity, In press
   Google Scholar
• Volpé R, Karlsson A, Jansson R, Dahlberg PA. Thyrostatic drugs act through modulation of thyroid cell activity to induce remissions in Graves' disease. Acta Endo 1987; 115: 305–311, Supplement 281
   Google Scholar
• Fort J G, Cowchock F S, Abruzzo J L, Smith JB. Anticardiolipin antibodies in patients with rheumatic diseases. Arthritis Rheum 1987; 30: 752–60
   PubMedGoogle Scholar
• Ingram S B, Goodnight S H, Bennett RM. An unusual syndrome of a devasting noninflammatory vasculopathy associated with anticardioplipin antibodies: report of two cases. Arthritis Rheum 1987; 30: 1167–72
   PubMedGoogle Scholar
• Manthorpe R, Frost-Larsen K, Isager H, Prause JU. Sjögren's syndrome. A review with emphasis on immunological features. Allergi 1981; 36: 139–53
   Google Scholar
• Loizou S, McCrea J D, Rudge AC. Measurement of anti-cardiolipin antibodies by an enzyme-linked immunosorbent assay (ELISA): standardization and quantitation of results. Clin Exp Immunol 1985; 62: 738–45
   PubMed Web of Science ®Google Scholar
• Sontheimer RD. The anticardiolipin syndrome. A new way to slice an old pie, or a new pie to slice. Arch Dermatol 1987; 123: 590–95
   PubMedGoogle Scholar